Manaʻo ʻia ʻo SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) no ka ʻike qualitative o SARS-CoV-2 Antigen (Nucleocapsid protein) i nā specimens swab nasal in vitro. Pono e ʻike hou ʻia ma ka hoʻohui ʻana i ka mōʻaukala o ka mea maʻi a me nā ʻike diagnostic ʻē aʻe[1]. ʻAʻole hoʻokaʻawale nā ​​hopena maikaʻi i ka maʻi bacterial a i ʻole nā ​​maʻi viral ʻē aʻe. ʻAʻole ʻike ʻia nā pathogens ke kumu nui o nā hōʻailona maʻi. ʻAʻole hoʻokaʻawale nā ​​hopena maikaʻi ʻole i ka maʻi SARS-CoV-2, a ʻaʻole pono ke kumu wale nō no ka mālama ʻana a i ʻole nā ​​​​hoʻoholo hoʻokele maʻi (me nā hoʻoholo hoʻoholo i ka maʻi maʻi). E hoʻolohe i ka moʻolelo pili hou o ka mea maʻi, ka mōʻaukala olakino a me nā hōʻailona like a me nā hōʻailona o COVID-19, inā pono, ua ʻōlelo ʻia e hōʻoia i kēia mau laʻana e ka hoʻāʻo PCR no ka hoʻokele maʻi. a loaʻa iā ʻoe ka ʻike ʻoihana no ka maʻi in vitro, no nā limahana kūpono i loaʻa i ka hoʻomalu maʻi a i ʻole ka hoʻomaʻamaʻa kahu hānai[2].